This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.

Dev

Joined: October 9, 2025
Articles: 6278

survey

Phosphorylation of kinesin light chain and calsyntenin-1/alcadein mediated axonal transport and processing of APP in Alzheimer’s disease

Phosphorylation of kinesin light chain and calsyntenin-1/alcadein mediated axonal transport and processing of APP in Alzheimer’s disease Investments < €500k United Kingdom 2016

Dev
April 20, 2018

survey

Alzheimer’s Research UK South Coast Network Centre Grant

Alzheimer’s Research UK South Coast Network Centre Grant Investments < €500k United Kingdom 2016

Dev
April 20, 2018

survey

Alzheimer’s Research UK Bristol and Bath Network Centre Grant

Alzheimer’s Research UK Bristol and Bath Network Centre Grant Investments < €500k United Kingdom 2016

Dev
April 20, 2018

survey

Phenotyping the immune response in Alzheimer’s disease by flow cytometry

Phenotyping the immune response in Alzheimer’s disease by flow cytometry Investments < €500k United Kingdom 2016

Dev
April 20, 2018

survey

Double-blind randomised crossover placebo-controlled pilot trial with intra-nasal Oxytocin to increase social cognitive function and reduce carer burden in frontotemporal dementia.

Double-blind randomised crossover placebo-controlled pilot trial with intra-nasal Oxytocin to increase social cognitive function and reduce carer burden in frontotemporal dementia. Investments < €500k United Kingdom 2016

Dev
April 20, 2018

survey

Title: Alpha-Synuclein and Cellular Iron Reduction

Title: Alpha-Synuclein and Cellular Iron Reduction Investments < €500k United Kingdom 2016

Dev
April 20, 2018

survey

Functional deficits in a novel murine model of frontotemporal lobar degeneration

Functional deficits in a novel murine model of frontotemporal lobar degeneration Investments < €500k United Kingdom 2016

Dev
April 20, 2018

survey

2nd Neurodegeneration Conference

2nd Neurodegeneration Conference Investments < €500k United Kingdom 2016

Dev
April 20, 2018

survey

Ensuring High Quality DNA and RNA isolation from the Brains for Dementia Research (BDR) Resource using the Agilent 2200 TapeStation Nucleic Acid System.

Ensuring High Quality DNA and RNA isolation from the Brains for Dementia Research (BDR) Resource using the Agilent 2200 TapeStation Nucleic Acid System. Investments < €500k United Kingdom 2016